𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tic suppression in the treatment of Tourette's syndrome with exposure therapy: The rebound phenomenon reconsidered

✍ Scribed by Cara W.J. Verdellen; Cees A.L. Hoogduin; Ger P.J. Keijsers


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
64 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Exposure and response prevention (ER), a behavioral treatment program consisting of exposure to premonitory sensory experiences during prolonged tic suppression, was shown to be a promising new treatment for tics in Tourette's syndrome (TS). In this study, the commonly reported paradoxical increase in tic frequency following voluntary tic suppression, i.e., rebound phenomenon, was examined. Tic frequency was rated in 20 TS patients during 15‐minute videotaped conversations taken both before and following 10 ER sessions. In addition, tic frequency was obtained at home by family members of the patients during 15‐minute daily tic frequency registrations. Ratings following ER sessions were compared with ratings obtained before the sessions. Neither the ratings at the institute nor the ratings at home supported a rebound effect following ER tic suppression. Β© 2007 Movement Disorder Society


πŸ“œ SIMILAR VOLUMES


Exposure and Response Prevention in the
✍ Kees Hoogduin; Cara Verdellen; Danielle Cath πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 156 KB πŸ‘ 2 views

The present article describes a new treatment method for Gilles de la Tourette's Syndrome, consisting of 10 2-hour sessions of exposure and response prevention. This method is based on the notion expounded by Bliss (1980) that patients with this syndrome often produce the tics voluntarily in order t

Botulinum toxin injection into vocal cor
✍ Burton L. Scott; Dr. Joseph Jankovic; Donald T. Donovan πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 310 KB

## Abstract We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improve

A trial of eltoprazine in the treatment
✍ Dr. J. Moriarty; B. Schmitz; M. R. Trimble; P. De Koning πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 494 KB πŸ‘ 1 views

We describe an exploratory double-blind placebo controlled trial of eltoprazine, a novel pharmacological agent, in the management of aggressive behaviours in two groups of patients: patients with epilepsy and patients with Gilles de la Tourette's Syndrome (GTS). The study was brought to a premature